US

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Republic of Korea *

molecular-glue-1920x640

Webinar

Development of an assay and screening platform to study molecular glue degraders

Discover how targeting RNA-binding motif protein 39 (RBM39) is unlocking new possibilities in cancer treatment. Learn from experts at Abbvie and Fraunhofer ITMP in the use of molecular glue degraders and advanced HTRF technology to quantify RBM39 degradation in neuroblastoma cancer cells.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

Have a sales representative contact me

First Name

Last Name

Country

Email Address

Company

Zip / Postal Code

Business Phone

Role

Products and Services of Interest

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

molecular-glue-degraders